ReviewCureus2025
Discharging Patients With Pending Microbiology Cultures: A Narrative Review of Safety and Best Practices.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pharmacist-led Transitions of Care Intervention to Address Infectious Disease Tests Pending at Discharge (TPAD).Open forum infectious diseases · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Discharging patients with pending microbiology culture results from the hospital has become a common practice aimed at improving hospital throughput and reducing length of stay. One of the main contributors to prolonged hospitalization is the delay in receiving finalized culture results, especially when patients are clinically stable and ready for discharge. Consequently, many hospitals have explored strategies to safely discharge patients before culture results are finalized. While this approach may help alleviate bed shortages and reduce healthcare costs, it raises important patient safety concerns. Finalized culture results may reveal pathogens or resistance patterns that necessitate changes in antimicrobial therapy. Without timely review and action, these findings can lead to missed diagnoses, suboptimal treatment, or avoidable readmissions. This narrative review synthesizes the current evidence on the safety, clinical impact, and system-level strategies associated with discharging patients with pending culture results. Studies show that 2%-11% of pending cultures in hospitalized patients require a change in clinical management, yet documentation of these pending results is often missing from discharge summaries, and follow-up responsibility is frequently unclear. Vulnerable populations, such as older adults and those discharged to subacute care facilities, are particularly at risk due to fragmented transitions and limited outpatient monitoring. Adverse outcomes in these groups include delayed therapy adjustments, inappropriate antimicrobial use, and increased healthcare utilization. To address these risks, several interventions have shown promise. These include electronic health record (EHR)-based alerts, pharmacist-led stewardship programs, and auto-populated discharge summary tools. When integrated into standardized discharge workflows and supported by institutional policy, these interventions improve follow-up rates and reduce harm. Systematic reviews of hospital discharge practices emphasize that multidisciplinary approaches, combining clinical teams, pharmacists, and care transition services, are most effective in ensuring timely review and response to finalized results. In conclusion, discharging patients with pending microbiology cultures can be safe when supported by structured systems that ensure results are reviewed and acted upon after discharge. Hospitals should implement protocols that clearly document pending tests, assign follow-up responsibility, and utilize EHR tools to facilitate communication. These strategies enhance both patient safety and operational efficiency during the vulnerable transition from inpatient to outpatient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.